Andrea Wahner Hendrickson

2.0k total citations
17 papers, 293 citations indexed

About

Andrea Wahner Hendrickson is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Andrea Wahner Hendrickson has authored 17 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Reproductive Medicine and 4 papers in Molecular Biology. Recurrent topics in Andrea Wahner Hendrickson's work include Ovarian cancer diagnosis and treatment (8 papers), PARP inhibition in cancer therapy (5 papers) and Chemotherapy-related skin toxicity (3 papers). Andrea Wahner Hendrickson is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), PARP inhibition in cancer therapy (5 papers) and Chemotherapy-related skin toxicity (3 papers). Andrea Wahner Hendrickson collaborates with scholars based in United States and Canada. Andrea Wahner Hendrickson's co-authors include Timothy J. Moynihan, Mark A. Lewis, Paul Haluska, Deepti Behl, Aminah Jatoi, Matthew S. Block, Nathan R. Foster, Erik Asmus, Tri A. Dinh and John A. Copland and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Andrea Wahner Hendrickson

16 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Wahner Hendrickson United States 8 146 79 64 61 32 17 293
Aude-Marie Savoye France 7 159 1.1× 41 0.5× 34 0.5× 82 1.3× 40 1.3× 19 312
Francesca Colonese Italy 10 171 1.2× 64 0.8× 85 1.3× 92 1.5× 34 1.1× 24 367
Alina Abramian Germany 11 165 1.1× 78 1.0× 46 0.7× 63 1.0× 57 1.8× 30 372
A. Hackshaw United Kingdom 8 244 1.7× 53 0.7× 57 0.9× 32 0.5× 34 1.1× 12 386
Angel Yordanov Bulgaria 9 109 0.7× 88 1.1× 70 1.1× 60 1.0× 92 2.9× 101 411
Jake Jacob United States 9 120 0.8× 95 1.2× 70 1.1× 50 0.8× 64 2.0× 23 324
J Crétin France 8 94 0.6× 32 0.4× 72 1.1× 70 1.1× 40 1.3× 31 257
Lindsay W. Brubaker United States 9 196 1.3× 246 3.1× 59 0.9× 108 1.8× 45 1.4× 28 514
Alejandro Gallego Spain 10 158 1.1× 42 0.5× 55 0.9× 50 0.8× 24 0.8× 28 279
Anna Castiglione Italy 12 65 0.4× 63 0.8× 94 1.5× 29 0.5× 76 2.4× 19 366

Countries citing papers authored by Andrea Wahner Hendrickson

Since Specialization
Citations

This map shows the geographic impact of Andrea Wahner Hendrickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Wahner Hendrickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Wahner Hendrickson more than expected).

Fields of papers citing papers by Andrea Wahner Hendrickson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Wahner Hendrickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Wahner Hendrickson. The network helps show where Andrea Wahner Hendrickson may publish in the future.

Co-authorship network of co-authors of Andrea Wahner Hendrickson

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Wahner Hendrickson. A scholar is included among the top collaborators of Andrea Wahner Hendrickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Wahner Hendrickson. Andrea Wahner Hendrickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lee, Elizabeth, Yinglu Zhou, Andrea Wahner Hendrickson, et al.. (2024). LB009/#1562  A phase II trial of pembrolizumab and lenvatinib in recurrent or persistent clear cell ovarian carcinoma (NCT05296512): stage 1 results. A11–A12. 1 indexed citations
2.
3.
4.
Block, Matthew S., Vera J. Suman, Wendy K. Nevala, et al.. (2023). A phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707) (1308). Gynecologic Oncology. 176. S189–S190. 1 indexed citations
5.
Gien, Lilian T., Danielle Enserro, Matthew S. Block, et al.. (2022). O014/#415 Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: an NRG oncology study. A9.1–A9. 1 indexed citations
6.
Liu, Joyce F., Stéphanie Gaillard, Andrea Wahner Hendrickson, et al.. (2021). An open-label phase II study of dostarlimab (TSR-042), bevacizumab (bev), and niraparib combination in patients (pts) with platinum-resistant ovarian cancer (PROC): cohort A of the OPAL trial. Gynecologic Oncology. 162. S17–S18. 23 indexed citations
7.
Colón‐Otero, Gerardo, Valentina Zanfagnin, Xiaonan Hou, et al.. (2020). Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. ESMO Open. 5(5). e000926–e000926. 61 indexed citations
8.
Marshall, Ariela L., Andrea Wahner Hendrickson, Rahma Warsame, et al.. (2020). Parental health in fellowship trainees: Fellows’ satisfaction with current policies and interest in innovation. Women s Health. 16. 1747083945–1747083945. 7 indexed citations
9.
Hendrickson, Andrea Wahner, et al.. (2019). Loratadine for Paclitaxel-Induced Myalgias and Arthralgias. American Journal of Hospice and Palliative Medicine®. 37(3). 235–238. 2 indexed citations
10.
Liu, Joyce F., Camille C. Gunderson, Andrea Wahner Hendrickson, et al.. (2019). Abstract CT157: An open-label Phase II study of combination of TSR-042, bevacizumab, and niraparib in patients with platinum-resistant ovarian cancer (OC): Cohort A of the OPAL trial. Cancer Research. 79(13_Supplement). CT157–CT157. 1 indexed citations
11.
Hendrickson, Andrea Wahner, et al.. (2018). Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer?. American Journal of Hospice and Palliative Medicine®. 36(1). 72–75. 5 indexed citations
12.
Jatoi, Aminah, Carmen Radecki Breitkopf, Nathan R. Foster, et al.. (2014). A Mixed-Methods Feasibility Trial of Protein Kinase C Iota Inhibition with Auranofin in Asymptomatic Ovarian Cancer Patients. Oncology. 88(4). 208–213. 28 indexed citations
13.
Swisher, E., James D. Brenton, Amit M. Oza, et al.. (2014). 215 Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib. European Journal of Cancer. 50. 73–73. 9 indexed citations
14.
Lewis, Mark A., Andrea Wahner Hendrickson, & Timothy J. Moynihan. (2011). Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment. CA A Cancer Journal for Clinicians. 61(5). 287–314. 83 indexed citations
15.
Gupta, Mamta, Andrea Wahner Hendrickson, Jing Han, et al.. (2010). Dual Inhibition of mTORC1/mTORC2 Induces Apoptosis of Mantle Cell Lymphoma by Preventing Rictor Mediated AKTS473 Phosphorylation by Potentiating AKT2-PHLPP1 Association. Blood. 116(21). 772–772. 6 indexed citations
16.
Behl, Deepti, Andrea Wahner Hendrickson, & Timothy J. Moynihan. (2009). Oncologic Emergencies. Critical Care Clinics. 26(1). 181–205. 29 indexed citations
17.
Hendrickson, Andrea Wahner & Paul Haluska. (2009). Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.. PubMed. 10(10). 1032–40. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aude-Marie Savoye Breakdown of academic impact, for papers by Francesca Colonese Breakdown of academic impact, for papers by Alina Abramian Breakdown of academic impact, for papers by A. Hackshaw Breakdown of academic impact, for papers by Angel Yordanov Breakdown of academic impact, for papers by Jake Jacob Breakdown of academic impact, for papers by J Crétin Breakdown of academic impact, for papers by Lindsay W. Brubaker Breakdown of academic impact, for papers by Alejandro Gallego Breakdown of academic impact, for papers by Anna Castiglione
Rankless by CCL
2026